跳至主要内容
临床试验/NCT04722211
NCT04722211Unknown不适用

Effects of Lactobacillus Plantarum PS128 on the Parkinsonian Symptoms in Parkinson's Disease.

Professor Lu Neurological Clinic2 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2020年7月6日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
120
试验地点
2
主要终点
TUG

研究概览

简要总结

This RCT study is designed to examine the extent to which L. plantarum PS128 can improve symptoms in PD patients. L. plantarum PS128 is a psychobiotic that regulates the level of dopamine in specific brain regions. Patients with PD will receive PS128 or placebo intervention for 12 weeks. Symptoms of PD will be clinically evaluated before and after the treatment, and the results will be compared.

详细描述

This RCT study is designed to examine the extent to which L. plantarum PS128 can improve symptoms in PD patients. L. plantarum PS128 is a psychobiotic that regulates the level of dopamine in specific brain regions. Patients with PD will receive PS128 or placebo intervention for 12 weeks. Symptoms of PD will be clinically evaluated before and after the treatment, and the results will be compared.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
45 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Modified Hoehn &Yahr stage, MHY 1-3
  • 45-80 years old
  • at least 9 years education

排除标准

  • Patients on antibiotics within the preceding one month
  • Patients using of other probiotic products (sachet, capsule or tablet) within the preceding two weeks
  • Have undergone surgery of liver, bladder, or gastrointestinal tract
  • Have current or history of inflammatory bowel disease
  • Have history of cancer
  • Known allergy to probiotics
  • Patients with comorbid dementia (Mini-Mental State Examination score ≤ 26) or major depression (The Beck Depression Inventory-II score ≥ 29)
  • Have received deep brain stimulation
  • Patients receiving artificial enteral or intravenous nutrition
  • Diagnosed before 40 years old
  • Poor control of other chronic diseases
  • Not eligible judged by PI

结局指标

主要结局

TUG

时间窗: 12 weeks

Observe the patient's postural stability, gait, stride length, sway and test cut-off times.

UPDRS III

时间窗: 12 weeks

The UPDRS scale refers to Unified Parkinson Disease Rating Scale, and it is a rating tool used to gauge the course of Parkinson's disease in patients. The PART III is Motor sections.

MHY

时间窗: 12 weeks

The Hoehn and Yahr scale is a commonly used system for describing how the symptoms of Parkinson's disease progress. The modified Hoehn and Yahr scale included stages 1 through 5. to help describe the intermediate course of the disease.

次要结局

  • UPDRS I-IV(Baseline and Post-12 weeks)
  • SCL-90-R(Baseline and Post-12 weeks)
  • VAS-GI(Baseline and Post-12 weeks)
  • CPSQI(Baseline and Post-12 weeks)
  • PGIC(Post-12 weeks)

研究者

发起方
Professor Lu Neurological Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

CHIN-SONG LU

Professor

Professor Lu Neurological Clinic

研究点 (2)

Loading locations...

相似试验